Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR)
XFOR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-13.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
130.10%
XFOR Stock Analysis
XFOR
PE Ratio:
XFOR
PEG Ratio:
Not Available
XFOR
Forward EPS Growth (12 month):
0.00%
XFOR
PS Ratio:
41.5
XFOR
PSG Ratio:
37.7
XFOR
Forward Revenue Growth (12 month):
1.10%
XFOR Articles
No data was found